SEC Filing Details

Investors

Document Details

Form
POS AM
Filing Date
March 24, 2022
Document Date
March 24, 2022
Form Description
Post-effective amendment to an S-Type filing
Filing Group
Registration Statements
Company
Jasper Therapeutics, Inc
Issuer
JASPER THERAPEUTICS, INC.
Top

External Link

You are now leaving the Jasper Therapeutics, Inc. site to a 3rd party website. Jasper Therapeutics is not responsible for 3rd party website content.

 

Continue
Cancel